Download Files:
RMI-61140
SKU
HY-101220-Get quote
Category Reference compound
Tags Dopamine Receptor, GPCR/G Protein;Neuronal Signaling, Neurological Disease
Products Details
Product Description
– RMI-61140 is an orally active neuroleptics. RMI-61140 decreases spontaneous motility and muscle tone in mice. RMI-61140 increases barbit urate-induced sleep and causes eyelid ptosis. RMI-61140 can be used for schizophrenia research[1].
Web ID
– HY-101220
Shipping
– Room temperature
Molecular Formula
– C23H23ClN2O5
References
– [1]Coscia L, et al. Pharmacological properties of new neuroleptic compounds. Arzneimittelforschung. 1975 Sep;25(9):1436-42.
CAS Number
– 24140-98-5
Molecular Weight
– 442.89
SMILES
– OC(/C=CC(O)=O)=O.ClC1=CC=C2OC3=CC=CC=C3C=C(N4CCN(CC4)C)C2=C1
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Dopamine Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.